{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:11:14Z","timestamp":1790514674598,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T00:00:00Z","timestamp":1365120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/leu.2013.99","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T05:47:10Z","timestamp":1365140830000},"page":"1617-1620","source":"Crossref","is-referenced-by-count":45,"title":["Personalized management of essential thrombocythemia\u2014application of recent evidence to clinical practice"],"prefix":"10.1038","volume":"27","author":[{"given":"A","family":"Tefferi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Barbui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"key":"BFleu201399_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.leu.2404955","volume":"22","author":"A Tefferi","year":"2008","unstructured":"Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14\u201322.","journal-title":"Leukemia"},{"key":"BFleu201399_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2010.69","volume":"24","author":"A Tefferi","year":"2010","unstructured":"Tefferi A . Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010; 24: 1128\u20131138.","journal-title":"Leukemia"},{"issue":"10","key":"BFleu201399_CR3","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/leu.2013.74","volume":"27","author":"T Barbui","year":"2013","unstructured":"Barbui T, Thiele J, Vannucchi AM, Tefferi A . Problems and pitfalls regarding WHO-defined diagnosis of early\/prefibrotic primary myelofibrosis versus essential thrombocythemia. Leukemia 2013; e-pub ahead of print 7 March 2013; doi: 10.1038\/leu.2013.74.","journal-title":"Leukemia"},{"key":"BFleu201399_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00277-004-0877-4","volume":"83","author":"JJ Michiels","year":"2004","unstructured":"Michiels JJ, Berneman Z, Schroyens W, Kutti J, Swolin B, Ridell B et al. Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia. Ann Hematol 2004; 83: 504\u2013512.","journal-title":"Ann Hematol"},{"key":"BFleu201399_CR5","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2006-03-008227","volume":"108","author":"M Boissinot","year":"2006","unstructured":"Boissinot M, Garand R, Hamidou M, Hermouet S . The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS). Blood 2006; 108: 1781\u20131782.","journal-title":"Blood"},{"key":"BFleu201399_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ajh.21543","volume":"85","author":"HM Kvasnicka","year":"2010","unstructured":"Kvasnicka HM, Thiele J . Prodromal myeloproliferative neoplasms: the 2008 WHO classification. Am J Hematol 2010; 85: 62\u201369.","journal-title":"Am J Hematol"},{"key":"BFleu201399_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ajh.22241","volume":"87","author":"A Carobbio","year":"2012","unstructured":"Carobbio A, Finazzi G, Thiele J, Kvasnicka HM, Passamonti F, Rumi E et al. Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia. Am J Hematol 2012; 87: 203\u2013204.","journal-title":"Am J Hematol"},{"key":"BFleu201399_CR8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.exphem.2009.07.005","volume":"37","author":"K Hussein","year":"2009","unstructured":"Hussein K, Bock O, Theophile K, von Neuhoff N, Buhr T, Schlue J et al. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis. Exp Hematol 2009; 37: 1186\u20131193 e1187.","journal-title":"Exp Hematol"},{"key":"BFleu201399_CR9","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol 2011; 29: 3179\u20133184.","journal-title":"J Clin Oncol"},{"key":"BFleu201399_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/leu.2011.258","volume":"26","author":"G Finazzi","year":"2012","unstructured":"Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M et al. Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria. Leukemia 2012; 26: 716\u2013719.","journal-title":"Leukemia"},{"key":"BFleu201399_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ajh.23217","volume":"87","author":"V Buxhofer-Ausch","year":"2012","unstructured":"Buxhofer-Ausch V, Gisslinger H, Thiele J, Gisslinger B, Kvasnicka HM, Mullauer L et al. Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early\/prefibrotic myelofibrosis: an international study of 264 patients. Am J Hematol 2012; 87: 669\u2013672.","journal-title":"Am J Hematol"},{"key":"BFleu201399_CR12","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/blood-2012-01-403279","volume":"120","author":"F Passamonti","year":"2012","unstructured":"Passamonti F, Thiele J, Girodon F, Rumi E, Carobbio A, Gisslinger H et al. A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. Blood 2012; 120: 1197\u20131201.","journal-title":"Blood"},{"key":"BFleu201399_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ajh.23135","volume":"87","author":"A Tefferi","year":"2012","unstructured":"Tefferi A . Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012; 87: 285\u2013293.","journal-title":"Am J Hematol"},{"key":"BFleu201399_CR14","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","volume":"117","author":"A Carobbio","year":"2011","unstructured":"Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 2011; 117: 5857\u20135859.","journal-title":"Blood"},{"key":"BFleu201399_CR15","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","volume":"120","author":"T Barbui","year":"2012","unstructured":"Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E et al. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood 2012; 120: 5128\u20135133, ; quiz 5252.","journal-title":"Blood"},{"key":"BFleu201399_CR16","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1182\/blood-2012-02-406645","volume":"119","author":"A Tefferi","year":"2012","unstructured":"Tefferi A . Overcoming \"aspirin resistance\" in MPN. Blood 2012; 119: 3377\u20133378.","journal-title":"Blood"},{"key":"BFleu201399_CR17","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1182\/blood-2011-06-359224","volume":"119","author":"S Pascale","year":"2012","unstructured":"Pascale S, Petrucci G, Dragani A, Habib A, Zaccardi F, Pagliaccia F et al. Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target. Blood 2012; 119: 3595\u20133603.","journal-title":"Blood"},{"key":"BFleu201399_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.thromres.2011.11.020","volume":"129","author":"MN Di Minno","year":"2011","unstructured":"Di Minno MN, Lupoli R, Palmieri NM, Russolillo A, Buonauro A, Di Minno G . Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update. Thromb Res 2011; 129: 341\u2013344.","journal-title":"Thromb Res"},{"key":"BFleu201399_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1182\/blood-2009-08-236679","volume":"115","author":"A Dragani","year":"2010","unstructured":"Dragani A, Pascale S, Recchiuti A, Mattoscio D, Lattanzio S, Petrucci G et al. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. Blood 2010; 115: 1054\u20131061.","journal-title":"Blood"},{"key":"BFleu201399_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1538-7836.2010.04115.x","volume":"9","author":"EL Grove","year":"2011","unstructured":"Grove EL, Hvas AM, Mortensen SB, Larsen SB, Kristensen SD . Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost 2011; 9: 185\u2013191.","journal-title":"J Thromb Haemost"},{"key":"BFleu201399_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","volume":"167","author":"JD Snoep","year":"2007","unstructured":"Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV . Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 1593\u20131599.","journal-title":"Arch Intern Med"},{"key":"BFleu201399_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1208500","volume":"368","author":"R Marchioli","year":"2013","unstructured":"Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D et al. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med 2013; 368: 22\u201333.","journal-title":"N Engl J Med"},{"key":"BFleu201399_CR23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood-2010-01-263319","volume":"116","author":"A Alvarez-Larran","year":"2010","unstructured":"Alvarez-Larran A, Cervantes F, Pereira A, Arellano-Rodrigo E, Perez-Andreu V, Hernandez-Boluda JC et al. Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. Blood 2010; 116: 1205\u20131210, quiz 1387.","journal-title":"Blood"},{"key":"BFleu201399_CR24","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/leu.2012.12","volume":"26","author":"T Barbui","year":"2012","unstructured":"Barbui T . How to manage children and young adults with myeloproliferative neoplasms. Leukemia 2012; 26: 1452\u20131457.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu201399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201399","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T06:49:20Z","timestamp":1715150960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,5]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFleu201399"],"URL":"https:\/\/doi.org\/10.1038\/leu.2013.99","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.721619025.793516202","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,5]]}}}